Drug Profile
RDX 024
Alternative Names: RDX-024Latest Information Update: 28 Jun 2020
Price :
$50
*
At a glance
- Originator Ardelyx
- Class
- Mechanism of Action Microbiome modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Gastrointestinal disorders; Heart failure; Kidney disorders
Most Recent Events
- 28 Jun 2020 No recent reports of development identified for research development in Gastrointestinal-disorders in USA
- 28 Jun 2020 No recent reports of development identified for research development in Heart-failure in USA
- 28 Jun 2020 No recent reports of development identified for research development in Kidney-disorders in USA